IP Expert

Overview

Naomi Pearce is a market-leading patent lawyer, patent attorney, and trademark attorney with over 25 years of experience and a background in molecular biology/biochemistry. 

Recognised as an industry leader, Naomi is ranked in IAM Patent 1000 and IAM Strategy 300, named a MIP “Patent Star,” and listed as a WIPR Leader for patents and trademarks. She is the 2023 Lawyers Weekly “IP Partner of the Year,” the 2022 Lexology Client Choice Award recipient for Life Sciences, the 2022 Asia Pacific Women in Business Law “Patent Lawyer of the Year,” and the 2021 Lawyers Weekly Women in Law SME “Partner of the Year.” 

Naomi founded Pearce IP in 2017, which was named “IP Team of the Year” at the 2021 Australian Law Awards and continues to earn accolades. 

Naomi’s legal expertise is underpinned by deep industry knowledge gained through her roles as VP of IP at global pharmaceutical companies and as a partner at a top-tier international law firm. Clients value Naomi’s creative, pragmatic solutions and her leadership in patent litigation, freedom-to-operate clearances, and strategic advice. 

She excels in managing Australian patent litigation and complex multi-jurisdictional cases. Naomi has worked with international agents on US Hatch-Waxman and BPCIA proceedings, CA PMNOC actions, and litigations across Europe, Asia, and Australasia, as well as patent oppositions before the EPO, AU, and NZ. Her global litigation expertise enables her to craft and coordinate sophisticated, multi-faceted litigation strategies aligned with clients’ commercial goals. 

Naomi’s primary focus is the life sciences sector, including pharmaceuticals, biopharmaceuticals (small and large molecules such as peptides, conjugates, and mAbs), personalised and precision medicine, radiopharmaceuticals, psychedelics, medical marijuana, medical devices, biotechnology, veterinary healthcare, ag-tech, food-tech, med-tech, gene editing (CRISPR), and gene and cell therapies. She is highly regarded for her work assisting pharma/biopharma clients in preparing for generic and biosimilar launches, drawing on her 13 years of global biosimilars leadership at Pfizer (Hospira) and Mylan. 

Additionally, Naomi advises clients on food standards, regulatory compliance (FSANZ), labelling, and packaging requirements, offering a comprehensive legal service for the life sciences industry.